REGN
Regeneron Pharmaceuticals Inc.
Latest News for REGN
In a report released today, Mohit Bansal from Wells Fargo maintained a Hold rating on Regeneron, with a price target of $825.00. Bansal covers the ......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Medios AG (MEDOF), Regeneron (REGN) and Siemens Heal......
In a report released on March 20, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron, with a price target of $967.00. The comp......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Electrocore (ECOR) and Regeneron (REGN) with bullish......
Friday may be a volatile day for the S&P 500 (SPX) and the Nasdaq 100 (NDX), as $5.7 trillion worth of options tied to individual U.S. stocks, inde......
Regeneron Pharmaceuticals ($REGN), Sanofi SA ($SNY) announced an update on their ongoing clinical study. The Impact of Dupilumab Treatment on Anxie......
Jefferies analyst Akash Tewari maintained a Buy rating on Regeneron today and set a price target of $890.00. Tewari covers the Healthcare sector, f......
News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $767.85 | -1.0% | 594.46K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW